GlassScriptPhysician profile
Salina D Green
NPI 1508985953
$2,267.01
in general payments reported to CMS, 2019-2025
25 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $78.95 · 2021: $216 · 2022: $419 · 2023: $432 · 2024: $297 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $827.20 |
| Education | $168.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $389.70 | 2022-2025 | Veozah |
| Abbvie INC. | $283.64 | 2019-2025 | |
| Allergan, INC. | $263.84 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $206.42 | 2019-2025 | |
| Organon LLC | $179.71 | 2021-2025 | Nexplanon |
| Exeltis, USA INC. | $158.51 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $117.61 | 2019-2025 | Aptima, Thinprep 2000 Processor, Third Wave |
| Sumitomo Pharma America, INC. | $103.67 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $83.67 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.21 | 2019-2025 | Gardasil 9 |
| Pfizer INC. | $52.97 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $50.49 | 2021-2025 | |
| Avion Pharmaceuticals | $48.65 | 2020-2023 | Balcoltra |
| Coopersurgical, INC. | $34.41 | 2023-2025 | Endosee, Paragard T 380a |
| Aesculap, INC. | $32.30 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $30.94 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.90 | 2019 | |
| Therapeuticsmd, INC. | $30.00 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $20.84 | 2019 | |
| Amgen INC. | $19.32 | 2024 | Prolia, Evenity |
| Vertical Pharmaceuticals, LLC | $16.78 | 2019 | |
| Optumhealth Care Solutions, LLC | $16.00 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Agile Therapeutics, INC. | $14.78 | 2021 | |
| Smith+Nephew, INC. | $14.71 | 2019 | |
| Sage Therapeutics, LLC | $13.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salina Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.